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Although the number of candidates on the kidney
transplant waiting list at year-end rose from 40 825
to 76 070 (86%) between 1998 and 2007, recent growth
principally reflects increases in the number of patients
in inactive status. The number of active patients in-
creased by ‘only’ 4510 between 2002 and 2007, from
44 263 to 48 773. There were 6037 living donor and
10 082 deceased donor kidney transplants in 2007. Pa-
tient and allograft survival was best for recipients of
living donor kidneys, least for expanded criteria donor
(ECD) deceased donor kidneys, and intermediate for
non-ECD deceased donor kidneys. The total number
of pancreas transplants peaked at 1484 in 2004 and
has since declined to 1331. Among pancreas recipi-
ents, those with simultaneous pancreas-kidney (SPK)
transplants experienced the best pancreas graft sur-
vival rates: 86% at 1 year and 53% at 10 years. Be-
tween 1998 and 2006, among diabetic patients with
end-stage renal disease (ESRD) who were under the
age of 50 years, 23% of all and 62% of those waitlisted
received a kidney-alone or SPK transplant. In contrast,
6% of diabetic patients aged 50–75 years with ESRD
were transplanted, representing 46% of those wait-
listed from this cohort. Access to kidney-alone or SPK
transplantation varies widely by state.
Key words: Access to transplantation, deceased
donors, diabetes mellitus, expanded criteria donors,
kidney transplantation, living donor, OPTN, pancreas
transplantation, simultaneous pancreas-kidney trans-
plantation, SRTR, survival, waiting list
Introduction
The first two sections of this article will review recent
trends in kidney and pancreas transplant waiting list ac-
tivity, transplant rates and outcomes. The remainder will
focus on access for patients with diabetes and end-stage
renal disease (ESRD) to the national Organ Procurement
and Transplantation Network (OPTN) kidney or simultane-
ous pancreas–kidney (SPK) transplant waiting lists and on
access by transplant candidates with diabetes to living
donor, deceased donor kidney-alone and SPK transplan-
tation. Both candidate age and geographic location con-
tribute importantly to access to the waiting list and to
transplantation opportunities for patients with diabetes.
The influence of these variables on rates of wait-listing
and transplantation will be examined.
Unless otherwise noted, the statistics in the sections on
kidney and pancreas transplantation are drawn from the
reference tables of the 2008 OPTN/SRTR Annual Report.
Statistics for the third section about transplantation in pa-
tients with diabetes are drawn from both the reference
tables and from special analyses prepared by the Scien-
tific Registry of Transplant Recipients (SRTR). Additional
information about the methods of data collection and anal-
ysis may be found in the data tables themselves and in
the Technical Notes of the Annual Report, both online at
http://www.ustransplant.org.
Kidney Transplantation
Number of transplants and size of active waiting list
Over the past 10 years, the annual number of kid-
ney transplants performed nationally grew by 31%, from
12 318 transplants in 1998 to 16 119 transplants in 2007
[Table 1.7]. During this period, the total number of candi-
dates listed for a kidney-alone transplant at any time during
the calendar year increased by 78%, from 53 315 to 94 741
[Table 5.3], while the total number of candidates waitlisted
for a kidney-alone transplant at year-end rose by 86%, from
38 690 to 71 862 [Table 1.3]; (Figure 1). Growth in the
number of waitlisted patients has been accompanied by a
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Source: 2008 OPTN/SRTR Annual Report, Tables 1.3, 5.2, 5.3
Figure 1: Number of new and prevalent kidney waiting list
patients and deaths on the waiting list, 1998 to 2007.
similar increase of 76% in deaths on the waiting list, from
2528 in 1998 to 4452 in 2007 [Table 5.3]. However, while
the absolute number of deaths has increased, it is notable
that the annual death rate for waiting list candidates has
decreased from a high of 84 deaths per 1000 patient-years
at risk in 1999 to 65 deaths per 1000 patient-years at risk in
2007 [Table 5.3]. During this period, the annual death rate
for waiting list candidates aged 50–64 years dropped from
100 deaths to 74 deaths per 1000 patient-years at risk,
while the death rate for candidates aged 65 years or older
dropped from 151 to 105. Most notably, the death rate for
waiting list candidates with diabetes dropped from 149 in
1999 to 97 in 2007. While it is probable that these trends
reflect improvements in dialysis outcomes, they may
also reflect changes in transplant candidate selection and
preparation.
Between December 31, 2002 and December 31, 2007, the
total number of candidates on the national kidney trans-























Figure 2: Active/inactive status of kidney waiting list candi-
dates at year-end, 1998–2007.
ever, not all of the components of the waiting list grew
proportionally. While the number of active patients on the
waiting list rose by 10% [Table 5.1a], most of the recent
growth in the overall size of the waiting list reflects an in-
crease in the use of Status 7 (inactive status), as the num-
ber of inactive patients on the waiting list grew by 282%
[Table 5.1b]. Specifically, the number of active patients,
34 496 on December 31, 1998, rose to 44 263 at the end
of 2002; but, by the end of 2007, only an additional 4510
patients had been added to the active candidate list, bring-
ing the total number of active candidates on December 31,
2007 to 48 773. In contrast, the number of inactive patients
on the kidney transplant waiting list increased slowly, from
4194 candidates at year-end in 1998 to 6038 candidates
in 2002, and then nearly quadrupled to 23 089 patients by
December 31, 2007. This increase in the use of Status 7
has been attributed to recent changes in OPTN policy that
now allow waitlisted candidates to accrue waiting time dur-
ing the entire period that they are listed, whether active or
inactive (1).
The proportion of candidates on the active kidney trans-
plant waiting list over the age of 50 years has increased
during the past decade from 44% to 58% [Table 5.1a];
(Table 1). This shift in the age distribution of the waiting
list reflects changes in the rates of waitlisting of the dif-
ferent age groups. New waitlistings for candidates under
50 years increased 26%, from 11 469 to 14 407 during
1998–2007, whereas the number of candidates aged 50
years or older more than doubled, from 8704 in 1998 to
18 436 in 2007 [Table 5.2]. The number of active candi-
dates younger than 50 years grew from 19 221 in 1998 to
21 245 in 2003 but remained between 20 349 and 20 579
over the next 4 years. The number of active candidates
over age 50 years rose from 15 275 in 1998 to 24 234 in
2003, and then to 28 243 in 2008 [Table 5.1a]. In contrast,
the number of inactive candidates younger than 50 years
increased from 2187 in 1998 to 3553 in 2003, and then to
9029 by 2007. The number of inactive candidates over 50
years grew from 2007 in 1998 to 4498 in 2003, and then
to 14 060 in 2007 [Table 5.1b]. As shown in Table 1, the
percentage of candidates by age group on the waiting list
in either active or inactive status is roughly proportional to
their representation on the total waiting list.
The distribution of race among candidates active on the
kidney waiting list has also changed over the past 10 years
(Table 1). The number of white and African American active
candidates grew from 15 113 and 12 493, respectively, in
1998 to 18 467 and 16 632 in 2007 [Table 5.1a]. At the
same time, however, the percentage of white candidates
on the active waiting list declined from 44% to 38% and
the percentage of African American candidates decreased
slightly from 36% to 34%. The total number of active His-
panic/Latino candidates more than doubled, from 4320 in
1998 to 8827 in 2007; Asian candidates also increased
over the same time, from 2154 to 4148 [Table 5.1a]. These
changes are reflected by a proportionate increase in the
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Table 1: Annual number and distribution of kidney waiting list patients by patient characteristic and status at year-end, 1998–2007
Active (%) Inactive (%)
Characteristic 1998 2003 2007 1998 2003 2007
N 34 496 45 479 48 773 4194 8051 23 089
<35 years 19 15 12 17 13 12
35–49 years 37 32 30 36 31 28
50–64 years 36 40 42 36 41 43
65+ years 9 13 16 12 15 18
White 44 39 38 48 41 39
African American 36 36 34 37 40 38
Hispanic/Latino 13 16 18 10 14 17
Asian 6 8 9 4 4 5
Other/multirace 1 1 1 2 2 2
Glomerular diseases 24 23 21 23 21 18
Diabetes 24 26 28 25 26 31
Hypertensive nephrosclerosis 17 20 22 12 18 21
Other 36 32 29 39 35 31
Source: Tables 5.1a and b and SRTR analysis, November 2008.
percentage representation of Hispanic/Latino and Asian
candidates in both active and inactive status on the waiting
list.
The pattern of diagnoses (glomerular diseases, hyperten-
sive nephrosclerosis, diabetes and other diseases) of can-
didates on the active kidney waiting list has also evolved
over the past 10 years (Table 1). Overall, the percentage
of active candidates with diabetes and hypertension has
increased, from 24% to 28% and from 17% to 22%, re-
spectively, whereas the percentage with glomerular dis-
ease has declined, from 24% to 21%. In 2007, the dis-
tribution of diagnoses was roughly proportional between
active and inactive candidates on the waiting list [Tables
5.1a and b]. Thus, it does not appear that the increased
fractions of listed older, minority, diabetic or hypertensive
candidates are driving the increased use of the Status 7
designation.
Among new candidates listed between 1998 and 2004,
there has been relatively little change in the median time
to receive any kidney transplant, that is, from either a de-
ceased or living donor. In 1998, the median time to any
kidney transplant was 1153 days; in 2004 (the most recent
year for which this calculation is possible), the median time
to any kidney transplant was 1219 days [Table 5.2].
Kidney donation and transplant trends
The annual number of deceased donor kidney transplants,
including multiorgan transplants but excluding SPK trans-
plants, rose from 8032 transplants in 1998 to a peak of
10 659 in 2006, and then fell to 10 586 transplants in 2007
[Table 5.4]. Non-SPK multiorgan transplants doubled, from
252 in 2002 to 504 in 2007 [Table 1.8]. In 2007, kidney–
liver (444) and kidney–heart (55) made up over 99% of
these transplants.
During the same time interval, the number of stan-
dard criteria donor (SCD) transplants, expanded criteria
donor (ECD) transplants, and non-ECD transplanted kid-
neys recovered through donation after cardiac death (DCD)
grew by 15%, 49%, and 929%, respectively [Table 5.4]
(Figure 3).
In these analyses, the ECD definition includes DCD kid-
neys that meet the OPTN ECD criteria. In 2007, there were
7729 SCD, 1828 ECD (101 of which were ECD/DCD) and
1029 DCD kidney transplants performed. The greatest nu-
merical increment compared with 2002 has been in DCD
transplants, with a gain of 765. SCD increased by 739,
and ECD (includes ECD/DCD) by 543 [Table 5.4]. There
were 73 fewer total transplants in 2007 (10 586) than in
2006 (10 659); this change represented 239 fewer SCD,
11 more ECD (includes ECD/DCD) and 155 more DCD
transplants [Table 5.4]. Although the percentage of SCD
kidneys allocated to candidates younger than 50 years has
declined, from 59% in 1998 to 48% in 2007 [Table 5.4a],
these younger candidates continued to receive SCD kid-
neys at a higher rate than their proportion on the waiting


























Source: 2008 OPTN/SRTR Annual Report, Table 5.4
HRSA Collaboratives began in April 2003 
Figure 3: SCD, ECD and DCD kidney transplants, 1998–2007.
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Conversion Rates
Discard Rates
HRSA Collaboratives began in April 2003 
Figure 4: Average conversion and discard rates for all organ
procurement organizations, 2002–2007.
The 24% growth in deceased donor kidney transplantation
since 2002 appears to be largely driven by the increase in
conversion rates [Table 5.4]; (Figure 4). This rate is defined
as the number of deceased donors who met eligibility cri-
teria for donation divided by the number of eligible deaths
defined as any ventilated death reported by a hospital that
is evaluated and that meets organ donor eligibility require-
ments. Nationally, the average conversion rate grew from
48% in 2002 to 67% in 2007 (Figure 4). In contrast, the
counterbalancing average discard rate was 13% in 2002
and 18% in 2007. Conversion rates may have been af-
fected by the efforts of the Health Resources and Services
Administration Transplant Growth and Management Col-
laboratives, which began in 2003.
There were 6037 living donor kidney transplants in 2007
[Table 5.4d]. This represents a 37% increase in the num-
ber of living donor transplants compared with 1998. Trends























Source: 2008 OPTN/SRTR Annual Report, Table 5.4d
Related
Unrelated








































Living Donor non-ECD ECD
Source: 2008 OPTN/SRTR Annual Report, Tables 5.14a, b, d . 
Figure 6: Unadjusted 1-year (2005–2006), 5-year (2001–2006)
and 10-year (1996–2006) kidney recipient survival, by donor
type.
shown in Figure 5. The number of living-related kidney
donors grew from 3456 in 1998 to 4349 in 2001, where it
remained roughly constant until 2004 at 4342. Since then,
the number of living-related donors has decreased, falling
to 3625 in 2007. From 1998 to 2006, the number of living-
unrelated kidney donors grew steadily from 908 to 2348,
with a decline in 2007 to 2154. The declines in living dona-
tion may reflect reconsideration by some kidney transplant
programs of the use of older, hypertensive, diabetic, obese
or minority living donors (2–7). The decrease in living do-
nation does not appear to be related to donor sex or race
[Table 2.9].
Kidney transplant patient and allograft survival trends
At the end of 2006, 103 312 patients had a functioning
kidney transplant compared with 64 779 in 1998, an in-
crease of 59% [Table 5.16]. For single kidney transplants
(multiorgan and SPK transplants excluded) performed prior
to 2006, 1-, 5- and 10-year patient survival was best for re-
cipients of living donor kidneys, intermediate for non-ECD
deceased donor recipients and lowest for those receiving
ECD kidneys (Figure 6). Unadjusted patient survival rates
at 5 years were 91% for recipients of living donor kidneys,
83% for non-ECD deceased donor kidneys and 70% for
ECD kidney transplants (Table 2).
Kidney allograft survival followed the same pattern as that
seen for recipient survival (Figure 7). Graft survival was
Table 2: Unadjusted graft and patient survival at 5 years among
deceased donor (non-ECD and ECD) and living donor kidney trans-
plant recipients, 1994–1999 and 2000–2005
Graft survival (%) Patient survival (%)
Donor type 1994–1999 2000–2005 1994–1999 2000–2005
Living donor 79.4 81.1 90.1 90.6
Non-ECD 68.3 70.7 82.8 83.3
ECD 51.7 55.3 70.4 69.5
Source: Tables 5.10a, b and c and SRTR analysis, November 2008.





































Living Donor non-ECD ECD
Source: 2008 OPTN/SRTR Annual Report, Tables 5.10a, b, d .
Figure 7: Unadjusted 1-year (2005–2006), 5-year (2001–2006)
and 10-year (1996–2006) kidney graft survival (death is in-
cluded as an event), by donor type.
best for recipients of living donor kidneys, intermediate
for non-ECD transplants and lowest for ECD transplants.
At 5 years, the unadjusted graft survival rate was 81%
for living donor, 71% for non-ECD and 55% for ECD trans-
plants (Table 2). Although kidney transplant patient survival
percentages were not different when the first 5 years of
the decade were compared with the second half (all, p >
0.05), there was a significant trend toward improvement in
allograft survival (all, p < 0.05).
Pancreas Transplantation
Pancreas transplant waiting list trends
The number of pancreata recovered peaked at 2045 in
2005, fell slightly in 2006 to 2032, and fell further in 2007 to
1927 [Table 1.1]. At the end of 2007, there were 3836 peo-
ple waiting for a solid organ pancreas transplant, 2314 for
an SPK, 932 for a pancreas after kidney (PAK) and 590 for a
pancreas transplant alone (PTA). This was a 73% increase
over the total number in 1998, indicating a growing dis-
crepancy between the number of candidates waitlisted for
pancreas transplantation and organs available [Table 1.3].
Correspondingly, there was an increase in waiting times
for all types of pancreas candidates. The median wait-
ing time for a PAK transplant has increased from about
220 days for candidates on the list in the late 1990s to 751
days for candidates placed on the list in 2005 [Table 1.5].
The median waiting time for an SPK transplant has risen
from 404 days in 1998 to 448 days in 2007 [Table 1.5]. The
greatest growth over the past decade in waitlisted patients
has been among those waiting for a PAK transplant (415%)
or a PTA (109%); in contrast, the number of SPK transplant
candidates increased by ‘only’ 32% [Table 1.3].
It is notable, however, that there have been recent down-
ward trends in registrations for SPK, PAK and total pan-
creas transplant (Figure 8). The total number of new pan-
creas waiting list registrations grew from 1931 in 1998 to



























All Pancreas SPK PAK PTA
Source: 2008 OPTN/SRTR Annual Report, Table 1.5. 
Figure 8: New registrations on pancreas waiting list, by trans-
plant type, 1998–2007.
PAK waiting list registrations rose from 179 in 1998 to
a high of 623 in 2004, falling to 385 in 2007. New SPK
registrations rose from 1535 in 1998 to a high of 2007
in 2000, and then declined to 1622 in 2007. PTA regis-
trations show continued-–albeit modest-–growth between
1998 and 2007, from 217 to 392 [Table 1.5].
Pancreas transplant trends
The overall number of pancreas transplants rose from 1216
in 1998, peaked at 1484 in 2004 and has since declined to
1331 (Figure 9). The number of SPK transplants peaked
in 1998 and the number of PAK transplants in 2004. The
cause of this decrease in pancreas transplant numbers is
uncertain, but has been attributed to several factors: kid-
ney payback debts precluding SPK transplantation within
‘debtor’ organ procurement organizations (OPOs), an un-
even distribution of pancreas transplant programs across
the United States, caution by many transplant programs in
the acceptance of pancreata recovered outside their own
donor service area, and age and obesity trends in the donor
population (8). The preponderance of pancreas transplants
























All Pancreas SPK PAK PTA
Source: 2008 OPTN/SRTR Annual Report, Tables 6.4, 7.4, 8.4.
Figure 9: Pancreas transplants, by transplant type, 1998–
2007.
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Figure 10: Number of recipients living with a functioning pan-
creas transplant at end of year, 1998–2006.
Pancreas transplant patient and allograft survival
trends
Despite trends toward fewer pancreas transplants and
waiting list registrations, the total number of patients
alive with a functioning pancreas allograft increased 78%,
from 5364 in 1998 to 9556 in 2005, but then declined
slightly to 9453 in 2006 (Figure 10). The largest relative in-
creases over the past 9 years occurred in the PAK and PTA
populations, both of which experienced roughly 4-fold in-
creases. Nonetheless, SPK recipients represent by far the
largest cohort of patients alive with a functioning pancreas
allograft.
Patient survival rates were similar for SPK, PAK and PTA
recipients at 1 year (ranging from 95% to 98%) and
3 years (ranging from 91% to 93%; Figure 11). The 5- and
10-year unadjusted patient survival rates were statistically
(p ≤ 0.05) lowest for PAK recipients at 84% and 65%, re-
spectively, and higher for SPK (87% and 70%, respectively)
and PTA recipients (89% and 73%, respectively) [Table
1.13]. Among pancreas recipients, those with SPK trans-
plants experienced the best unadjusted pancreas graft sur-
vival rates: 86% at 1 year (p = 0.08) and 53% at 10 years
(p < 0.001; Figure 12). Graft survival rates for PAK and PTA
recipients were lower than for SPK recipients, with 1-year
rates of 77% and 81%, respectively, and 10-year rates of
35% and 26%, respectively [Table 1.13].
Kidney Transplantation in Patients
with Diabetes
Trends in diabetes among patients with end-stage
renal disease
In 2007 compared with 1999, the percentage of pa-
tients with diabetes among all, among active and among
newly waitlisted adult kidney-alone candidates increased
(Table 3). Among all waitlisted candidates, the highest per-
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Source: 2008 OPTN/SRTR Annual Report, Table 1.13.
Figure 11: Unadjusted 1-, 3-, 5- and 10-year pancreas patient
survival, by transplant type.
Americans and the lowest percentages within the white
and African American populations (Figure 13). The great-
est rates of increase are seen in African Americans, His-
panic/Latinos and Asians. However, much of the overall
increase can be explained by the increase in the average
age of waitlisted kidney transplant candidates (Figure 14).
The average slope for the increase in patients with diabetes
on the waiting list is 0.79 percentage points/year, whereas
the average slope for the increase in this group when ad-
justed for age is 0.37 percentage points/year. Thus, the
increasing age of waitlisted candidates explains roughly
more than half of the growth in the percentage of patients
with diabetes on the waiting list.
Age and geography appear to contribute importantly to
differences in access to waitlisting and kidney transplan-
tation among diabetic subpopulations. Data from the Cen-
ters for Medicare and Medicaid Services (CMS) and the
OPTN/SRTR are used in the following analyses of these
factors. The CMS database includes information on all
dialysis patients in the United States. The OPTN/SRTR




























Source: 2008 OPTN/SRTR Annual Report, Table 1.13.
Figure 12: Unadjusted 1-, 3-, 5- and 10-year pancreas graft
survival (death is included as an event), by transplant type.
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Table 3: Change in the percentage of patients with diabetes
among waitlisted adult kidney-alone candidates by race, from 1998
to 2007
Change in % diabetics
On waiting Active on New listings
Candidate list waiting list throughout
race January 1st January 1st year
African American +6 +5 +8
Hispanic/Latino +8 +7 +9
Native American +4 +4 +5
White +1 –1 +3
Asian/Pacific Islander +11 +9 +14
Source: SRTR analysis, November 2008.
candidates and recipients in the United States. Both data
sources were supplemented with vital status information
from the Social Security Death Master File (9). Since kid-
ney transplants are rarely performed on patients older than
75 years, the following waitlisting and transplant data dis-
cussions are limited to patients younger than 75 years at
time of entry into the study. Information on type I versus
type II diabetes was not available for all subsets of candi-
dates and recipients included in these analyses. Therefore,
for patients with diabetes, access to the waiting list and
transplantation was analyzed in the context of two age co-
horts: younger (<50 years old) and older (50–75 years of
age).
Nationally, between 1998 and 2006, the total number of
patients between 0 and 75 years with ESRD from diabetes
mellitus (DM; n = 313 061)—defined as beginning dialysis
(n = 303 666), being preemptively waitlisted (n = 8492),
or receiving a preemptive living donor transplant without
prior placement on the waiting list (n = 903)—has grown
steadily for patients both under and over the age of 50
years (Table 4). In 1998, the incident number of patients
with ESRD from diabetes who were under the age of 50
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Figure 13: Percentage of diabetics among all waitlisted adult
























































Source: SRTR analysis, using data as of November 2008.
Percentage Points of Change in Diabetics/Year 
Average slope (curve not shown), unadjusted: 0.79%/year
Average slope (curve not shown), adjusted for age: 0.37%/year
Figure 14: Percentage of diabetics and average age among
newly waitlisted adult kidney-alone candidates by year listed.
years or between 50 and 75 years were 6090 and 24 828,
respectively. By 2006 those numbers had grown to 7143
and 30 704, increases of 17% and 24%, respectively.
Access to the waiting list and to transplantation for
patients with diabetes and end-stage renal disease
Between 1998 and 2006, 22 046 (38%) of the 58 617 U.S.
patients with diabetes and ESRD who were under the age
of 50 years were waitlisted and 13 693 were transplanted
with either a living or deceased donor kidney-alone or an
SPK transplant (Table 5). Thus, 23% of the total younger
diabetic ESRD population and 62% of the younger dia-
betic waitlisted cohort received a kidney transplant. Within
this cohort, 3509 patients with diabetes were preemptively
waitlisted; among that group, 2596 (74%) were eventu-
ally transplanted. Of the younger patients with diabetes
who were preemptively waitlisted, 792 were also preemp-
tively transplanted: 486 from a living donor and 306 from a
deceased donor. An additional 1804 transplants occurred
among these preemptively waitlisted candidates after they
began dialysis: 447 from living donor and 1357 from de-
ceased donor sources. In addition, during this period, 449
patients with diabetes under age 50 years were trans-
planted preemptively from a living donor without ever be-
ing waitlisted. This brings the total number of preemptive
transplants among younger patients with diabetes to 1241,
of which 75% were, not surprisingly, from living donors.
Transplant rates were lower among non-preemptively wait-
listed diabetics under the age of 50 years, and the ratio
of living to deceased donation among these patients was
nearly the inverse of that seen among those who were
preemptively transplanted. Some 18 537 patients with di-
abetes under the age of 50 years were waitlisted after
beginning dialysis; of these, 10 648 (57%) received a kid-
ney transplant: 3162 (30%) from a living donor and 7486
(70%) from a deceased donor.
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Table 4: Number of patients aged 0–75 years with diabetes as the primary cause of ESRD: (a) beginning dialysis; (b) preemptively
waitlisted and (c) receiving a preemptive living donor kidney transplant who were never waitlisted
Entry criterion 1998–2006 1998 1999 2000 2001 2002 2003 2004 2005 2006
Age < 50 years
Began dialysis N 54 659 5657 5732 5999 5922 5985 6145 6233 6245 6741
Preemptively waitlisted N 3509 390 401 436 365 376 349 373 438 381
Received preemptive living N 449 43 53 47 57 68 55 66 39 21
donor transplant, never waitlisted
Total N 58 617 6090 6186 6482 6344 6429 6549 6672 6722 7143
Age 50+ years
Began dialysis N 249 007 24 472 25 748 26 822 27 977 27 890 28 460 28 768 29 049 29 821
Preemptively waitlisted N 4983 337 372 445 474 483 607 658 779 828
Received preemptive living N 454 19 34 30 52 44 61 74 85 55
donor transplant, never waitlisted
Total N 254 444 24 828 26 154 27 297 28 503 28 417 29 128 29 500 29 913 30 704
Source: SRTR analyses, November 2008 using OPTN and CMS data.
Of 306 preemptively waitlisted, younger patients with di-
abetes who received a preemptive deceased donor kid-
ney transplant, 132 (43%) received an SPK transplant.
In contrast, 934 (69%) of the 1357 preemptively wait-
listed, younger diabetic recipients who were transplanted
with a deceased donor kidney after beginning dialysis
received SPK transplants and 3643 (49%) of the 7486
non-preemptively waitlisted, younger diabetic recipients
who underwent deceased donor kidney transplantation re-
ceived an SPK transplant. Thus, preemptively waitlisted,
younger diabetic kidney transplant recipients who were
preemptively transplanted were more likely to receive a
living donor kidney transplant and less likely to receive an
SPK transplant than were those who were not preemp-
tively transplanted, whether preemptively waitlisted or not.
During this same period, a comparatively smaller percent-
age (35 897/254 444, 14%), of older ESRD patients with
Table 5: Allocation outcomes of study population by entry criterion: patients with diabetes aged 0–75 years whose first ESRD treatment
was during 1998–2006
Preemptive transplants Not preemptive transplants
Waitlisted Waitlisted All Living Deceased Deceased Living Deceased Deceased
N KI SPK transplants donor donor KI donor SPK donor donor KI donor SPK
Entry criterion, age < 50
Began dialysis 54 659 13 182 5355 10 648 − − − 3162 3843 3643
Preemptively waitlisted 3509 1 852 1657 2596 486 174 132 447 423 934
Received preemptive living 449 − − 449 449 − − − − −
donor transplant
never waitlisted
Total 58 617 15 034 7012 13 693 935 174 132 3609 4266 4577
Entry criterion, age 50–75
Began dialysis 249 007 30 132 782 13 185 − − − 4290 8418 477
Preemptively waitlisted 4983 4657 326 2788 569 456 32 453 1149 129
Received preemptive living 454 − − 454 454 − − − − −
donor transplant
never waitlisted
Total 254 444 34 789 1108 16 427 1023 456 32 4743 9567 606
Source: SRTR analyses, November 2008 (KI = kidney-alone transplant; SPK = simultaneous pancreas–kidney transplant).
diabetes, aged 50–75 years, were waitlisted (Table 5). Of
those waitlisted candidates, 16 427 (46%) were trans-
planted, representing 6% of all patients with diabetes
and ESRD in this age group. Among older patients with
diabetes, 4983 were preemptively waitlisted; within this
group of candidates, 2788 (56%) were eventually trans-
planted. Of the older patients with diabetes who were pre-
emptively waitlisted, 1057 were also preemptively trans-
planted: 569 from a living donor and 488 from a deceased
donor. An additional 1731 transplants occurred among
these preemptively waitlisted candidates after they be-
gan dialysis: 453 from living donor and 1278 from de-
ceased donor sources. Furthermore, during this period,
454 older patients with diabetes were transplanted pre-
emptively from a living donor without ever being placed on
the waiting list. This brings the total number of preemptive
transplants among older diabetics to 1511, of which 68%
were from living donors.
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Table 6: Allocation outcomes by entry criterion: patients with diabetes waitlisted for SPK transplantation aged 0–75 years whose first
ESRD treatment was during 1998–2006
Preemptive transplants Not preemptive transplants
Waitlisted All Living Deceased Deceased Living Deceased Deceased
SPK transplants donor donor KI donor SPK donor donor KI donor SPK
Entry criterion, age < 50, SPK waiting list
Began dialysis 5355 3730 − − − 492 326 2912
Preemptively waitlisted 1657 1349 214 0 132 184 117 702
Total 7012 5079 214 0 132 676 443 3614
Entry criterion, age 50–75, SPK waiting list
Began dialysis 782 490 − − − 72 61 357
Preemptively waitlisted 326 248 57 0 32 21 42 96
Total 1108 738 57 0 32 93 103 453
Source: SRTR analyses, November 2008 (KI = kidney-alone transplant; SPK = simultaneous pancreas–kidney transplant).
As was seen in younger patients with diabetes, transplan-
tation rates and the ratio of living to deceased donation
were lower among older diabetic patients who were not
preemptively waitlisted compared with those who were.
Some 30 914 older patients with diabetes were waitlisted
after beginning dialysis and 13 185 (43%) received a kidney
transplant: 4290 (33%) from a living donor and 8895 (67%)
from a deceased donor.
Simultaneous pancreas–kidney transplantation rates were
much lower among older compared with younger patients
with diabetes. Of the 488 preemptively waitlisted, older
diabetic patients who received a preemptive deceased
donor kidney transplant, 32 (7%) received an SPK trans-
plant; 129 (7%) of the 1731 preemptively waitlisted, older
diabetic patients who were transplanted after beginning
dialysis received SPK transplants and 477 (5%) of the 8895
non-preemptively waitlisted, older patients with diabetes
who underwent deceased donor kidney transplantation re-
ceived an SPK transplant.
Access to the simultaneous pancreas-kidney waiting
list and to SPK transplantation for diabetic patients
with end-stage renal disease
More than 7000 younger patients with diabetes were listed
for SPK transplantation: 1657 were listed preemptively
and 5355 were listed after beginning dialysis (Table 6).
Of those preemptively listed, 1349 (81%) received trans-
plants, as did 3730 (70%) of those not listed preemptively.
Of these recipients, 834 (62%) of those who were pre-
emptively listed received SPK transplants; however, only
132 of those SPK transplants were preemptive. An addi-
tional 2912 (54%) SPK transplants went to the 5355 candi-
dates who were listed after the initiation of chronic main-
tenance dialysis. Of the preemptively waitlisted recipients,
398 ultimately received living donor kidney transplants; the
number of living donor transplants for non-preemptively
waitlisted recipients was 492. Respectively, 117 and 326
of the preemptively and non-preemptively waitlisted can-
didates ultimately received deceased donor kidney-alone
transplants.
Far fewer older candidates with diabetes were listed for
SPK and received either SPK or kidney-alone transplants.
Overall, 1018 older patients with diabetes were listed, 326
preemptively and 782 after beginning dialysis. Transplants
were performed in 248 (76%) of the preemptively listed
candidates; 490 (63%) of those not listed preemptively
received transplants. Of preemptively listed candidates,
128 (39%) received SPK transplants but only 32 of those
transplants were preemptive. An additional 357 (46%) SPK
transplants went to the 782 candidates who were listed
after the initiation of chronic maintenance dialysis. Ulti-
mately, 78 of the preemptively waitlisted candidates and 72
of those not preemptively waitlisted received living donor
kidneys. Respectively, 42 and 61 of the preemptively and
non-preemptively waitlisted candidates ultimately received
deceased donor kidney-alone transplants.
Geographic variation in access to kidney and to
simultaneous pancreas–kidney transplantation for
patients with diabetes and end-stage renal disease
Table 7 shows by state of residence the number and per-
centage of patients who were waitlisted and the percent-
age of patients who received a transplant during the study
period. Among younger patients with diabetes were the
following findings. The percentage of ESRD patients per
state who were waitlisted for either a kidney or an SPK
transplant ranged over twofold, from 23% to 57%, with a
national mean of 38%. The percentage receiving a living
donor kidney transplant ranged more than tenfold, from
3% to 36%, with a mean of 8%. The percentage receiving
a kidney-alone deceased donor transplant ranged twelve-
fold, from 2% to 19%, with a mean of 8%. And the per-
centage of SPK transplants ranged more than sevenfold,
from 3% to 22%, with a mean of 8%. Overall, the ratio
between deceased and living donor transplants was 2.0.
Among older patients with diabetes, the following findings
were observed. The percentage of ESRD patients per state
who were waitlisted for either a kidney or an SPK transplant
ranged more than fourfold, from 6% to 24%, with a mean
of 14%. The percentage receiving a living donor kidney
902 American Journal of Transplantation 2009; 9 (Part 2): 894–906
ROTSOT Kidney and Pancreas Transplantation, 1998–2007
Table 7: Percentage of patients with diabetes (by age) placed on the kidney waiting list and receiving a transplant by state, 1998–2006
Age < 50 years Age 50–75 years
Waitlisted Living Deceased Deceased Waitlisted Living Deceased Deceased
for KI or donor donor KI donor SPK for KI or donor donor KI donor SPK
or SPK transplants transplants transplants SPK transplants transplants transplants
State N (%) (%) (%) (%) N (%) (%) (%) (%)
AK 66 40.9 13.6 1.5 12.1 241 14.5 3.3 5.4 0.4
AL 1272 39.1 8.2 5.1 4.2 4611 13.9 1.8 2.0 0.0
AR 635 26.5 6.9 10.1 4.6 2211 7.0 1.8 3.6 0.2
AZ 1345 33.4 7.8 5.9 6.3 5448 14.0 3.1 3.5 0.2
CA 6532 50.5 5.0 6.4 8.5 30 788 21.8 1.7 3.6 0.3
CO 626 47.3 11.5 8.3 11.5 2358 19.6 3.3 4.7 0.1
CT 447 33.8 12.8 6.5 2.9 2275 10.8 2.5 2.5 0.0
DC 252 30.2 5.6 4.8 5.2 1065 15.4 2.0 3.2 0.4
DE 197 39.6 8.6 7.6 3.0 757 20.1 2.1 6.2 0.4
FL 2972 28.9 3.4 7.1 10.1 13 876 10.2 1.2 4.3 0.3
GA 2149 23.2 2.8 4.4 7.6 8344 8.5 0.9 3.0 0.3
HI 401 31.4 2.7 6.5 4.0 1986 15.4 1.4 2.7 0.0
IA 400 46.0 12.3 10.0 16.5 1712 15.4 4.3 6.7 0.2
ID 192 34.9 13.5 10.9 9.9 546 13.7 3.8 6.8 0.2
IL 2258 45.2 7.7 7.9 11.5 10 289 15.5 2.9 4.0 0.4
IN 1185 37.6 7.6 8.4 14.1 5048 10.2 2.0 3.9 0.5
KS 405 29.9 5.4 8.1 10.1 1756 7.9 1.6 3.6 0.6
KY 875 28.3 4.0 6.3 11.1 3489 8.4 1.3 3.9 0.5
LA 1347 26.9 3.9 5.0 8.2 5771 8.2 1.1 2.3 0.3
MA 738 48.5 21.4 10.8 3.9 3647 19.7 3.6 6.2 0.2
MD 1088 40.2 10.4 9.4 7.4 5269 17.7 3.1 5.2 0.4
ME 135 41.5 16.3 7.4 8.9 755 11.1 3.0 4.8 0.0
MI 2145 42.3 13.8 8.8 6.0 8845 15.1 3.8 4.2 0.1
MN 683 51.2 36.0 9.4 7.5 2377 24.0 10.1 7.5 0.9
MO 1117 32.6 6.6 8.1 6.9 4937 11.0 2.1 4.3 0.3
MS 836 31.2 3.1 7.7 4.7 3146 8.7 1.0 1.7 0.0
MT 153 45.1 19.6 9.8 11.8 543 20.6 6.8 9.0 0.4
NC 2070 28.9 4.6 5.0 7.6 8246 10.4 1.6 2.7 0.3
ND 146 43.8 26.0 7.5 9.6 469 21.7 7.9 9.2 0.2
NE 284 36.6 10.6 8.8 13.7 1205 12.6 3.5 5.1 0.2
NH 156 41.7 14.7 14.1 5.1 586 14.8 2.2 7.2 0.3
NJ 1439 46.8 11.9 8.7 6.8 7671 17.3 3.0 3.9 0.2
NM 527 31.5 7.4 8.3 3.6 2133 11.3 2.2 3.4 0.0
NV 375 40.0 5.1 11.2 7.7 1799 16.0 2.0 3.6 0.2
NY 3176 41.0 10.3 8.6 4.3 16 098 16.5 2.6 3.7 0.2
OH 2416 35.4 10.0 7.3 12.4 11 557 10.4 3.0 3.4 0.3
OK 880 25.1 3.6 7.4 5.2 3157 10.0 1.2 4.4 0.2
OR 512 30.5 10.0 12.1 8.8 1842 11.4 3.9 6.8 0.1
PA 2238 50.8 8.8 10.5 12.6 11 131 17.3 1.9 6.5 0.4
PR 965 22.7 4.1 5.0 4.9 4761 5.6 0.8 1.4 0.0
RI 146 56.8 24.7 18.5 4.1 643 11.7 4.2 4.5 0.0
SC 1073 26.8 4.4 5.6 7.5 4695 8.6 0.7 3.4 0.2
SD 164 50.6 18.9 15.2 9.1 660 24.1 4.4 10.2 0.6
TN 1397 33.5 7.5 8.4 8.9 5222 10.2 1.8 3.4 0.2
TX 6127 31.9 4.4 7.8 4.4 23 951 12.6 1.5 3.6 0.1
UT 342 30.7 18.1 9.4 12.9 1039 11.7 6.5 7.3 0.3
VA 1541 40.6 9.2 6.1 7.1 6565 14.9 3.3 3.1 0.1
VT 50 44.0 18.0 8.0 12.0 175 17.7 2.9 9.1 0.0
WA 852 38.7 9.0 8.0 12.8 3357 14.0 3.1 5.2 0.3
WI 827 52.5 9.4 8.7 21.6 3355 18.1 4.5 6.3 0.8
WV 405 34.8 9.1 13.1 6.7 1859 9.1 1.8 3.4 0.1
WY 58 48.3 19.0 8.6 6.9 178 15.2 3.4 6.7 0.0
All 58 617 37.6 7.8 7.6 8.0 254 444 14.1 2.3 3.9 0.3
Source: SRTR analysis, November 2008 (KI = kidney-alone transplant; SPK = simultaneous pancreas–kidney transplant).
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Adjusted for age, sex, year of ESRD start, race, and insurance status
95th %ile=2.1
Figure 15: Percentiles (5th, 25th, 50th, 75th, 95th) of adjusted
relative access rates compared with national average, 1998–
2006, diabetes mellitus (DM) as cause, age < 50 years.
transplant ranged more than tenfold, from 0.7% to 10.1%,
with a mean of 2.3%. The percentage receiving a kidney-
alone deceased donor transplant ranged sevenfold, from
1.4% to 10.2%, with a mean of 4%. And the percentage of
SPK transplants ranged from 0.0% to 0.9%, with a mean
of 0.3%. Overall, the ratio between deceased and living
donor transplants was 1.8.
These geographic differences in the rates of waitlisting
(Figures 15 and 16) and transplantation (Figures 17 and 18)
persisted even after adjusting for candidate age, race, sex,
insurance status and year of ESRD. There was consider-
able geographic variation in listing rates for both younger
and older patients with diabetes. Table 8 presents some of
the correlations in the outcomes shown in Table 7 across
states. Transplant rates for various subgroups tended to
correlate with each other. In general, a high concordance
was seen between the listing rates of the two age groups
within a state; that is, states with high listing rates for
younger diabetic patients also had higher listing rates for





























Adjusted for age, sex, year of ESRD start, race, and insurance status
Insufficient data for adjusted relative KP Tx rate calculation
Figure 16: Percentiles of adjusted relative access rates com-
pared with national average, 1998–2006, DM as cause,
age ≥ 50 years.






























Adjusted for age, sex, year of ESRD start, race, and insurance status
95th %ile=2.5
Figure 17: Percentiles of adjusted relative access rates com-
pared with national average, 1998–2006, DM as cause,
age < 50 years.
older such patients and visa versa (between-state Pear-
son correlation coefficient = 0.78). Correlations were also
seen in transplantation rates between various subgroups.
States with high transplant percentages for patients with
diabetes tended to have high transplant percentages for
candidates without the disease. And, states with high
transplant percentages for younger candidates (age less
than 50 years) tended to have high transplant percentages
for older candidates. No distinction was made in the table
between kidney-alone and SPK when calculating correla-
tions between listing rates, but transplant rates are based
on kidney-alone transplants.
Summary
Over the past decade, the total number of candidates on
the kidney transplant waiting list at any time during the
calendar year increased by 78%, from 53 315 to 94 741.
However, the number of candidates active on the kidney

























Adjusted for age, sex, year of ESRD start, race, and insurance status
Insufficient data for adjusted relative KP Tx rate calculation
Figure 18: Percentiles of adjusted relative access rates com-
pared with national average, 1998–2006, DM as cause,
age ≥ 50 years.
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Table 8: Between-state correlation coefficients (r) for outcomes in Table 7
Donor ESRD cause Age Transplant (KI)/listing rate Distinction Correlation (r)
N/A DM Listing <50 vs. ≥50 years 0.78
Kidney 0–75 Transplant DM vs. non-DM 0.86
Kidney DM Transplant <50 vs. ≥50 years 0.90
Kidney Non-DM Transplant <50 vs. ≥50 years 0.88
Source: SRTR analysis, November 2008 (ESRD = end-stage renal disease; KI = kidney-alone transplant; N/A = not applicable).
transplant waiting list grew more slowly, increasing by only
16% since 2001. In contrast, the number of inactive pa-
tients on the kidney transplant waiting list nearly quadru-
pled since 2002 to 23 089. The annual number of deceased
donor kidney-alone transplants peaked at 10 212 in 2006
and then fell to 10 082 transplants in 2007. Similarly, the
number of living-related kidney donors reached 4349 in
2001 but decreased to 3625 in 2007; the number of living-
unrelated donor transplants peaked at 2348 in 2006 but
declined in 2007 to 2154. Unadjusted kidney transplant re-
cipient survival rates at 5 years were 91% for living donor
kidneys, 83% for non-ECD deceased donor kidneys and
70% for ECD kidney transplants; unadjusted graft survival
was 81% for living donor, 71% for non-ECD and 55% for
ECD transplants. There is a significant trend toward im-
provement in allograft survival (all p < 0.05) when the first
5 years of the last decade are compared with the second
half.
The overall number of pancreas transplants peaked at 1484
in 2004 and has since declined to 1331 by 2007. There
were also recent downward trends in SPK, PAK and to-
tal pancreas transplant registrations. The total number of
new pancreas waiting list registrations peaked at 2796 in
2000 and then fell to 2399 in 2007. Patient survival rates
were similar for PAK, SPK and PTA through the first three
posttransplant years, but the 5- and 10-year patient survival
rates were lower for PAK recipients: 65% at 10 years com-
pared with 70% and 73% for SPK and PTA recipients, re-
spectively. The best pancreas allograft survival rates, 86%
at 1 year and 53% at 10 years, were achieved with SPK
transplants. One-year graft survival rates for PAK and PTA
were 77% and 81%, respectively, and 10-year rates were
35% and 26%, respectively.
The age of candidates and the percentage of patients with
diabetes among all, among active and among newly wait-
listed adult kidney-alone candidates are increasing. The in-
creasing age of waitlisted candidates explains roughly half
of the growth in the percentage of diabetics on the wait-
ing list. Nationally, between 1998 and 2006, 23% of the
total population of patients with diabetes and ESRD who
were under the age of 50 years and 62% of the waitlisted
population of these patients, received a kidney or an SPK
transplant. During this same interval, 6% of such patients
aged 50–75 years, representing 46% of those waitlisted,
were transplanted. Among those preemptively waitlisted,
74% of candidates under the age of 50 years and 56% of
candidates between the ages 50 and 75 years were even-
tually transplanted. Among younger patients with diabetes:
the percentage of ESRD patients per state who were wait-
listed for either a kidney or an SPK transplant varied more
than twofold, the percentage receiving a living donor kid-
ney transplant more than tenfold, the percentage receiving
a kidney-alone deceased donor transplant twelvefold and
the percentage of SPK transplants more than sevenfold.
Among older patients with diabetes: the percentage of
ESRD patients per state who were waitlisted for either a
kidney or an SPK transplant ranged more than fourfold, the
percentage receiving a living donor kidney transplant more
than tenfold, the percentage receiving a kidney-alone de-
ceased transplant sevenfold and the percentage of SPK
transplants from 0.0% to 0.9%.
Overall, the percentage of patients with diabetes and
ESRD is increasing at a rate that is only partially explained
by the aging of the ESRD population. Age and geogra-
phy have emerged as powerful determinants of kidney and
SPK transplantation for this patient population. Based upon
these variables, marked variation among patients with di-
abetes is observed in living donor transplantation, waitlist-
ing and deceased donor transplantation rates. Preemptive
waitlisting is associated with better access to transplanta-
tion for both younger and older diabetic ESRD cohorts.
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